Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 2Unknown 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Sarcoma 14Osteosarcoma 9Drug-Related Side Effects and Adverse Reactions 4Gastrointestinal Stromal Tumors 2Uterine Neoplasms 1Neoplasms, Connective and Soft Tissue 1Neoplasm Metastasis 1Liposarcoma 1Head and Neck Neoplasms 1Chordoma 1Chondrosarcoma 1Carcinosarcoma 1Carcinoma 1

Interventions

apatinib 4Ifosfamide 2Filgrastim 2Etoposide 2selinexor 1glucarpidase 1camrelizumab 1Vincristine 1Radiotherapy 1Procarbazine 1Pharmaceutical Preparations 1Methotrexate 1Lomustine 1Imatinib Mesylate 1Genetic Therapy 1Fibroblast Growth Factor 7 1Drug Combinations 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × apatinib × Sarcoma × Clear all
NCT04824352 2024-05-14

AIEO

Peking University People's Hospital

Phase 2 Suspended
44 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Peking University People's Hospital

Phase NA Completed
79 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04260113 2021-01-05

AIAC

Peking University People's Hospital

Phase NA Completed
40 enrolled
Sarcoma

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04351308 2020-05-19

MAPAC

Peking University People's Hospital

Phase 2 Unknown
60 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡